Evidence map›Paper›PMID 36936168›Full record

ArticleFrontiers in endocrinology2023

Editorial: Double-edged swords: Important factors connecting metabolic disorders and cancer development - from basic research to translational applications.

Che-Pei Kung, Thibaut Barnoud, Cong-Hui Yao, Maureen E Murphy

Full text readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Metabolic convergence of diabetes and prostate cancer: from dysglycemia to tumor microenvironment reprogramming.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Che-Pei KungDivision of Molecular Oncology, Department of Medicine, School of Medicine, Washington University in St. Louis, Saint Louis, MO, United States.
Thibaut BarnoudDepartment of Biochemistry and Molecular Biology, College of Medicine, Medical University of South Carolina, Charleston, SC, United States.
Cong-Hui YaoDepartment of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA, United States.
Maureen E MurphyProgram in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, PA, United States.

Funding

Genetics of Tumor Suppression by p53R00CA241367 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BARNOUD, THIBAUT · 2022 to 2024
$747k
NCI NIH HHS R00 CA241367
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Metabolic DiseasesMetabolic SyndromeNeoplasmsHumanscancermetabolismmetabolomicsMetS (metabolic syndrome)microbiomeobesityp53translational research

Identifiers

PMID36936168
PMCPMC10019277

What OpenQuestion holds

Textfull text, public
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.